This content is from: Premium Why 2019 Wasn’t All Bad for Unicorns While the recent headlines were negative, 2019 was still a pretty good year for fund raising. By Stephen Taub December 30, 2019
This content is from: Portfolio Ten-fold Growth and a 740 Percent Stock Gain: Cathie Wood’s Breakout Year by the Numbers ARK Investment Management’s assets grew 11-fold to $34.5 billion over the course of 2020. By Amy Whyte January 20, 2021
This content is from: Premium Healthcare Hedge Funds Shine as This Year’s Winning Strategy Managers are plowing money into oncology and genomics-oriented companies — and reaping rewards. By Michelle Celarier October 08, 2018
This content is from: Premium Tiger Global, Viking, Maverick Eye IPOs Citadel and Farallon are also gearing up for private holdings going public. By Stephen Taub November 24, 2020
This content is from: Premium Biotech IPOs Are a Mixed Bag for Hedge Funds A recent spate of biotech company IPOs has yielded some early winners and losers. By Stephen Taub July 24, 2019
This content is from: Premium Viking’s Hybrid Fund Surges on Private Investments The fund, which invests in a mix of private and public funds, is way outpacing its better-known siblings. By Stephen Taub October 08, 2019
